Chronic oral administration of CI-994: a phase 1 study.
Prakash S, Foster BJ, Meyer M, Wozniak A, Heilbrun LK, Flaherty L, Zalupski M, Radulovic L, Valdivieso M, LoRusso PM.
Prakash S, et al. Among authors: lorusso pm.
Invest New Drugs. 2001;19(1):1-11. doi: 10.1023/a:1006489328324.
Invest New Drugs. 2001.
PMID: 11291827
Clinical Trial.